A549 Lung Cancer
A549 Lung Cancer - Related Videos
08:03
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
0 Views •
Cited by 7 •
2016
Photodynamic therapy (PDT) is an alternative choice for lung cancer treatment. To increase the therapeutic effect of PDT, lung cancer-targeted nanoparticles combined with chemotherapy were developed. Both in vitro and in vivo anticancer efficacies of PDT with prepared nanoparticles were evaluated.
05:17
Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
0 Views •
2025
This protocol describes an automated, ISO15189-accredited next-generation sequencing workflow for detecting targetable genomic alterations in non-small cell lung cancer (NSCLC) formalin-fixed paraffin-embedded tissues.
05:08
In Vitro Phototoxicity Assay: A PDT-based Method to Evaluate the Phototoxic Potential of a Photosensitizer in Lung Cancer Cells
0 Views •
2023
Photodynamic therapy (PDT) is a non-invasive and non-surgical method for lung cancer treatment. Photosensitizers selectively accumulate in tumor tissue and lead to tumor cell death in the presence of oxygen and the proper wavelength of light. In this protocol video, PDT-based method is used to evaluate the phototoxic potential of a potential photosensitizer in lung cancer cells.
06:57
Instillation and Fixation Methods Useful in Mouse Lung Cancer Research
0 Views •
Cited by 48 •
2015
The goal of this paper is to describe simple methods that will greatly aid in the setup and analysis of mouse lungs with lung cancer or other pathologies. We present 3 protocols to simply and reliably carry out lung instillations, fixation, and lung volume measurements.
11:17
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
0 Views •
2026
Here we present thoracoscopic extended sleeve lobectomy, an applicable procedure for patients with centrally located non-small-cell lung cancer that exceeds an anatomic lobe and improves the probability of complete resection while preserving respiratory capacity.
FAQs
Their genetic and phenotypic features provide an experimental context for examining signaling processes associated with lung cancer biology. Investigators can relate changes in proliferation, migration, or cell death to alterations in signaling activity under defined culture conditions. This helps connect molecular mechanisms with measurable cellular behaviors relevant to cancer research.
Proliferation, migration, and cell death offer complementary measures of treatment response. A candidate intervention may reduce cell growth, alter movement across a culture surface, or increase cellular death, and these outcomes can be assessed separately rather than treated as interchangeable. Examining multiple responses gives a broader view of how an agent affects tumor-like cell behavior.
Comparing results with other models helps determine whether an observed response is reproducible or specific to one cellular background. Such comparisons can also clarify mechanisms of treatment resistance and strengthen interpretation of candidate therapy results. In cancer research, this broader context reduces the risk of drawing conclusions from a single experimental system.
A typical workflow begins by maintaining the cells as an adherent epithelial monolayer under controlled culture conditions. Researchers then apply the treatment, radiation exposure, or delivery strategy being investigated and measure outcomes such as proliferation, migration, or cell death. Results can subsequently be compared across conditions or with other experimental models.
This model is useful when researchers need to examine chemotherapy, targeted agents, radiation, or nanoparticle delivery in a controlled in vitro setting. The resulting cellular responses can indicate whether an intervention changes growth, movement, or survival. These findings support early evaluation of candidate treatments before broader comparisons across cancer models.
Experiments can address how lung cancer cells respond to therapeutic stress, whether a treatment produces measurable changes in key cellular behaviors, and how delivery approaches influence those responses. Results also contribute to studies of resistance and reproducibility when investigators compare conditions or models. The system therefore connects treatment testing with mechanistic cancer research.